Avoid common mistakes on your manuscript.
Correction to: Mol Biomed 1, 6 (2020)
https://doi.org/10.1186/s43556-020-00007-y
In article [1], the authors would like to change the Competing Interests statement to below:
Competing interests
YW, HY and DG have patent 10669252 (Benzazepine derivative, preparation method, pharmaceuticalcomposition and use thereof). YW, HY, HL, SZ, YZ, PZ, XL, XS, LW, GF, YG, PW and DG are the employees of Shanghai Denovo Pharmatech Co., Ltd.. This work was supported by Shanghai Denovo Pharmatech Co., Ltd..
Reference
Wang Y, Yang H, Li H, Zhao S, Zeng Y, Zhang P, et al. Development of a novel TLR8 agonist for cancer immunotherapy. Mol Biomed. 2020;1(1):6. https://doi.org/10.1186/s43556-020-00007-y.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, Y., Yang, H., Li, H. et al. Correction to: Development of a novel TLR8 agonist for cancer immunotherapy. Mol Biomed 2, 16 (2021). https://doi.org/10.1186/s43556-021-00042-3
Published:
DOI: https://doi.org/10.1186/s43556-021-00042-3